High expression of the mutant COL11A1-activated gene signature was similarly associated with decreased survival in cervical cancer (HR = 1.41, 95% CI = 1.10–1.81, p = 6.29e–3) as well as lung SCC (HR = 1.16, 95% CI = 1.01–1.34, p = 3.79e−2), adding 27% and 26% more information, respectively, to a predictive model based on age, gender, clinical stage, and radiation therapy (Likelihood ratio test, p = 4.61e−3 and 3.66e−2) (Fig. 3d and SI Appendix, Fig. S4c–f). This evidence concerns the gene COL11A1 and cervical carcinoma.